Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Development and Validation of a Measure of Substance-Related Consequences: A Novel Clinical Outcome Assessment for Substance Use Disorder Trials

NCT07503067 is registered in ClinicalTrials.gov with Mclean Hospital as lead sponsor.

NCT NCT07503067
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07503067 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Development and Validation of a Measure of Substance-Related Consequences: A Novel Clinical Outcome Assessment for Substance Use Disorder Trials
Lead sponsor
Mclean Hospital
Phase
Observational
Overall status
Recruiting
Start date
February 10, 2026
Completion date
July 31, 2027
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

substance use disorder (sud)